Gambaran Tekanan Darah Pada Pasien Psoriasis Vulgaris Di Poliklinik Kulit & Kelamin Rumah Sakit Umum Pusat Haji Adam Malik Medan
34
DAFTAR PUSTAKA
Alberti, K.G.M.M., Zimmet, P., Shaw, J., 2006. Metabolic Syndrome - A new
world wide definition. A Consensus Statement from the International
Diabetes Federation. Diabet Med, 23 : 469 – 480.
Anggara, F.H.D., Prayitno, N., 2013. Faktor – Faktor yang berhubungan dengan
Tekanan darah di Puskesmas Telaga Murni, Cikarang Barat Tahun 2012.
Jurnal Ilmiah Kesehatan, 5(1) : 20 – 25.
Armstrong, A.W., Lin, S.W., Chambers, C.J., Sockolov, M.E., Chin, D.L., 2011.
Psoriasis and Hypertension Severity : Results from a Case-Control Study.
PLoS ONE, 6(3) : e18227.
Armstrong, E.P., Malone, D.C., 2003. The Impact of Non-steroidal Antiinflammatory Drugs on Blood Pressure, with an Emphasis on Newer
Agents. Clin Ther., 25 : 1 – 18.
Barnetson, R & White, A., 2006. Working in the tropics. In : Tyring, S.K., et al.,
eds. Tropical Dermatology. USA: Elsevier Inc, 22 – 26.
Bowcock, A.M., 2005. Understanding the pathogenesis of psoriasis, psoriatic
arthritis, and autoimmunity via a fusion of molecular genetics and
immunology. Immunologic Research, 32: 45-46.
Canadian Hypertension Education Program, 2013. Accurate Measurement of
Blood Pressure : Table 1. Recommended Technique for Measuring Blood
Pressure.
Hypertension
–
Canada.
Available
From
:
http://www.hypertension.ca/iframes/cheptables/table1.html?ml=1&ml=1&ml=
1
[Accessed 22 Mei 2013]
Cohen, A.D., Weitman, D., Dreiher, J., 2010. Psoriasis and Hypertension : A
Case-Control Study. Acta Derm Venereol, 90: 23 – 26.
Universitas Sumatera Utara
35
Cohen, A.D., Sherf, M., Vidavsky, L., Vardy, D.A., Shapiro, J., Meyerovitch, J.,
2008. Association between Psoriasis and the Metabolic Syndrome.
Dermatology, 216(2) : 152 – 155.
Department of Health and Human Services. 2003. The Seventh Report of The
Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure. The National Heart, Lung, and Blood
Institute, The Executive Committee.
Djuanda, A., 2010. Dermatosis Eritroskuamosa. Dalam : Djuanda, A., ed. Ilmu
Penyakit Kulit dan Kelamin. 6th ed. Jakarta: Balai Penerbit FK UI, 189-195.
Fisher, N.D.L. & Williams, G.H., 2005. Hypertensive Vascular Disease. In :
Kasper, D.L., et al., eds. Harrison’s Principle of Internal Medicine. 16th ed.
USA: McGraw-Hill, 1466.
Ghazali, M.V., Sastromihardjo, S., Soedjarwo, S.R., Soelaryo, T., Pramulyo, H.S.,
2008. Studi cross-sectional. Dalam : Sastroasmoro, S., Ismael, S., et al.,
eds. Dasar-dasar Metodologi Penelitian Klinis. Jakarta : Sagung Seto,
112-126.
Ghiasi, M., Nouri, M., Abbasi, A., Hatami, P., Abbasi, M.A., Nourijelyani, K.,
2011. Psoriasis and increased prevalence of hypertension and diabetes
mellitus. Indian J Dermatol, 56 : 533 – 536.
Griffiths, C.E. & Barker, J.N., 2007. Pathogenesis and Clinical Features of
Psoriasis. Lancet, 370 : 263 – 271.
Gudjonsson, J.E. & Elder, J.T., 2008. Psoriasis. In : Wolff K., et al., eds.
Fitzpatrick's Dermatology in General Medicine. 7th ed. USA: The
McGraw-Hill Companies, 169-193.
Universitas Sumatera Utara
36
Hayashi, R., Yamashita, N., Matsui, S., Fujita, T., Araya, J., Sassa, K., Arai, N.,
Yoshida, Y., Kashii, T., Maruyama, M., Sugiyama, E., Kobayashi, M.,
2000. Bradykinin stimulates IL-6 and IL-8 production by human lung
fibroblasts through ERK- and p38 MAPK-dependent mechanisms. Eur
Respir J, 16 : 452 – 458.
Huerta, C., Rivero, E., Rodriguez, L.A.G., 2007. Incidence and Risk Factors for
Psoriasis in the General Population. Arch Dermatol, 143(12) : 1559-1565.
Huskic, J., Mulabegovic, N., Alendar, F., Ostojic, L., Ostojic, Z., Simic, D.,
Milicevic, R., Naletilic, M., 2008. Serum and Tissue Angiotensin
Converting Enzyme in Patients with Psoriasis. Coll Antropol, 32 (4) :
1215-1219.
Icen, M., Crowson, C.S., McEvoy, M.T., Dann, F.J., et al., 2009. Trends in
incidence of adult-onset psoriasis over three decades : a population based
study. J Am Acad Dermatol, 60(3) : 394-401.
James, W.D., Berger, T.G., Elston, D.M., 2006. Andrew’s Diseases of the Skin.
10th ed. Philadelphia : Elsevier Inc, 193 – 201.
Kaplan, N.M., 2006. Kaplan’s Clinical Hypertension. 9th ed. Philadelphia :
Lippincott Williams & Wilkins, 103 – 104.
Kranzhofer, R., Schmidt, J., Pfeiffer, C.A.H., Hagl, S., Libby, P. Kubler, W., 1999.
Angiotensin Induces Inflammatory Activation of Human Vascular Smooth
Muscle
Cells.
Available
From:
http://atvb.ahajournals.org/content/19/7/1623.long
[Accessed 22 Mei 2013].
Kurd, S.H., Troxel, A.B., Crits-Christoph, P., Gelfand, J.M., 2010. The Risk of
Depression, Anxiety, and Suicidality in Patients With Psoriasis. Arch
Dermatol, 146(8) : 891 – 895.
Universitas Sumatera Utara
37
Lee, C.T., Williams, G.H., Lilly, L.S., 2011. Hypertension. In : Lilly, L.S., ed.
Pathophysiology of Heart Disease a collaborative project of medical
students and faculty. 5th ed. Philadelphia : Lippincott Williams & Wilkins,
301 – 323.
Madanagobalane, S., Anandan, S., 2012. Prevalence of Metabolic Syndrome in
South Indian Patients with Psoriasis Vulgaris and the Relation Between
Disease Severity and Metabolic Syndrome : A Hospital-Based CaseControl Study. Indian J Dermatol, 57 : 353 – 357.
Mukhtar, Z., 2011. Desain Penelitian. Dalam : Mukhtar, Z., ed. Desain Penelitian
Klinis dan Statistika Kedokteran. 1st ed. Medan : USU press, 72 – 75.
Murad, A & Tobin, A.M., 2012. Cardiovascular Disease in Inflammatory
Disorders – Psoriasis and Psoriatic Arthritis. Available From :
www.intechopen.com/download/pdf/32661.
[Accessed 2 December 2013]
Naldi, L., Chatenoud, L., Belloni, A., Peserico, A., et al., 2005. Cigarette smoking,
body mass index, and stressful life events as risk factors for psoriasis :
results from an Italian case-control study. J Invest Dermatol, 125: 61-67.
National Heart, Lung, and Blood Institute, 2010. What is Hypotension?.
Available From : http://www.nhlbi.nih.gov/health/health-topics/topics/hyp/
[Accessed 2 December 2013]
Niehof, M. & Borlak, J., 2011. HNFalpha Dysfunction as a Molecular Rational
for Cyclosporine Induced Hypertension. PLoS ONE, 6(1) : e16319.
Nestle, F.O., Kaplan, D.H., Barker, J., 2009. Mechanisms of disease Psoriasis. N
Eng J Med, 361: 469 – 509.
Universitas Sumatera Utara
38
Rocha-Pereira, P., Santos-Silva, A., Rebelo, I., Figueiredo, A., Quintanilha, A.,
Teixeira, F., 2001. Dislipidemia and oxidative stress in mild and in severe
psoriasis as a risk for cardiovascular disease. Clinica Chimica Acta,
303:
33-29.
Schön, M.P., Boehncke, W.H., 2005. Medical Progress Psoriasis. N Eng J Med,
352: 1899 – 1912.
Sherwood, L. 2010. Human Physiology from cells to systems. 7th ed. USA :
Cengage Learning, 350 – 351.
Siregar, R.S., 2000. Psoriasis. Dalam : Harahap, W., ed. Ilmu Penyakit Kulit.
Jakarta : Hipokrates, 116 – 126.
Sowers, J.R., 2002. Hypertension, Angiotensin II, and Oxidative Stress. N Engl J
Med, 346: 1999–2001.
Strom, J.B., Libby, P., 2011. Atherosclerosis. In : Lilly, L.S., ed. Pathophysiology
of Heart Disease a collaborative project of medical students and faculty.
5th ed. Philadelphia : Lippincott Williams & Wilkins, 113-134.
Sugiharto, A. 2007. Faktor-Faktor risiko Hipertensi grade II pada masyarakat
(Studi Kasus di Kabupaten Karanganyar). Tesis. Semarang : Program
Studi Epidemiologi Program Pasca Sarjana Universitas Diponegoro.
Tortora, G.J., Derrickson, B., 2012. The Cardiovascular System: Blood Vessels
and Hemodynamics. In: Roesch, B., et al., eds. Principles of Anatomy and
Physiology. 13th ed. USA: John Wiley & Sons, 817.
Tozawa, M., Oshiro, S., Iseki, C., Sesoko, S., Higashiuesato, Y., Tana, T.,
Ikemiya,Y., Iseki, K., Fukiyama, K., 2001. Family History of
Hypertension
and
Blood
Pressure
in
Screened
Cohort.
Hypertens Res, 24 : 93 – 98.
Universitas Sumatera Utara
39
Wakkee, M., Thio, H.B., Prens, E.P., Sijbrands, E.J.G., Neumann, H.A.M., 2007.
Unfavorable cardiovascular risk profiles in untreated and treated psoriasis
patients. Atherosclerosis, 190: 1 - 9.
Wandeler, G., Paccaud, F., Vollenweider, P., Waeber, G., Mooser, V., Bochud,
M., 2010. Strength of Family History in Predicting Levels of Blood
Pressure, Plasma Glucose and Cholesterol. Public Health Genomics, 13 :
143 – 154.
Universitas Sumatera Utara
DAFTAR PUSTAKA
Alberti, K.G.M.M., Zimmet, P., Shaw, J., 2006. Metabolic Syndrome - A new
world wide definition. A Consensus Statement from the International
Diabetes Federation. Diabet Med, 23 : 469 – 480.
Anggara, F.H.D., Prayitno, N., 2013. Faktor – Faktor yang berhubungan dengan
Tekanan darah di Puskesmas Telaga Murni, Cikarang Barat Tahun 2012.
Jurnal Ilmiah Kesehatan, 5(1) : 20 – 25.
Armstrong, A.W., Lin, S.W., Chambers, C.J., Sockolov, M.E., Chin, D.L., 2011.
Psoriasis and Hypertension Severity : Results from a Case-Control Study.
PLoS ONE, 6(3) : e18227.
Armstrong, E.P., Malone, D.C., 2003. The Impact of Non-steroidal Antiinflammatory Drugs on Blood Pressure, with an Emphasis on Newer
Agents. Clin Ther., 25 : 1 – 18.
Barnetson, R & White, A., 2006. Working in the tropics. In : Tyring, S.K., et al.,
eds. Tropical Dermatology. USA: Elsevier Inc, 22 – 26.
Bowcock, A.M., 2005. Understanding the pathogenesis of psoriasis, psoriatic
arthritis, and autoimmunity via a fusion of molecular genetics and
immunology. Immunologic Research, 32: 45-46.
Canadian Hypertension Education Program, 2013. Accurate Measurement of
Blood Pressure : Table 1. Recommended Technique for Measuring Blood
Pressure.
Hypertension
–
Canada.
Available
From
:
http://www.hypertension.ca/iframes/cheptables/table1.html?ml=1&ml=1&ml=
1
[Accessed 22 Mei 2013]
Cohen, A.D., Weitman, D., Dreiher, J., 2010. Psoriasis and Hypertension : A
Case-Control Study. Acta Derm Venereol, 90: 23 – 26.
Universitas Sumatera Utara
35
Cohen, A.D., Sherf, M., Vidavsky, L., Vardy, D.A., Shapiro, J., Meyerovitch, J.,
2008. Association between Psoriasis and the Metabolic Syndrome.
Dermatology, 216(2) : 152 – 155.
Department of Health and Human Services. 2003. The Seventh Report of The
Joint National Committee on Prevention, Detection, Evaluation, and
Treatment of High Blood Pressure. The National Heart, Lung, and Blood
Institute, The Executive Committee.
Djuanda, A., 2010. Dermatosis Eritroskuamosa. Dalam : Djuanda, A., ed. Ilmu
Penyakit Kulit dan Kelamin. 6th ed. Jakarta: Balai Penerbit FK UI, 189-195.
Fisher, N.D.L. & Williams, G.H., 2005. Hypertensive Vascular Disease. In :
Kasper, D.L., et al., eds. Harrison’s Principle of Internal Medicine. 16th ed.
USA: McGraw-Hill, 1466.
Ghazali, M.V., Sastromihardjo, S., Soedjarwo, S.R., Soelaryo, T., Pramulyo, H.S.,
2008. Studi cross-sectional. Dalam : Sastroasmoro, S., Ismael, S., et al.,
eds. Dasar-dasar Metodologi Penelitian Klinis. Jakarta : Sagung Seto,
112-126.
Ghiasi, M., Nouri, M., Abbasi, A., Hatami, P., Abbasi, M.A., Nourijelyani, K.,
2011. Psoriasis and increased prevalence of hypertension and diabetes
mellitus. Indian J Dermatol, 56 : 533 – 536.
Griffiths, C.E. & Barker, J.N., 2007. Pathogenesis and Clinical Features of
Psoriasis. Lancet, 370 : 263 – 271.
Gudjonsson, J.E. & Elder, J.T., 2008. Psoriasis. In : Wolff K., et al., eds.
Fitzpatrick's Dermatology in General Medicine. 7th ed. USA: The
McGraw-Hill Companies, 169-193.
Universitas Sumatera Utara
36
Hayashi, R., Yamashita, N., Matsui, S., Fujita, T., Araya, J., Sassa, K., Arai, N.,
Yoshida, Y., Kashii, T., Maruyama, M., Sugiyama, E., Kobayashi, M.,
2000. Bradykinin stimulates IL-6 and IL-8 production by human lung
fibroblasts through ERK- and p38 MAPK-dependent mechanisms. Eur
Respir J, 16 : 452 – 458.
Huerta, C., Rivero, E., Rodriguez, L.A.G., 2007. Incidence and Risk Factors for
Psoriasis in the General Population. Arch Dermatol, 143(12) : 1559-1565.
Huskic, J., Mulabegovic, N., Alendar, F., Ostojic, L., Ostojic, Z., Simic, D.,
Milicevic, R., Naletilic, M., 2008. Serum and Tissue Angiotensin
Converting Enzyme in Patients with Psoriasis. Coll Antropol, 32 (4) :
1215-1219.
Icen, M., Crowson, C.S., McEvoy, M.T., Dann, F.J., et al., 2009. Trends in
incidence of adult-onset psoriasis over three decades : a population based
study. J Am Acad Dermatol, 60(3) : 394-401.
James, W.D., Berger, T.G., Elston, D.M., 2006. Andrew’s Diseases of the Skin.
10th ed. Philadelphia : Elsevier Inc, 193 – 201.
Kaplan, N.M., 2006. Kaplan’s Clinical Hypertension. 9th ed. Philadelphia :
Lippincott Williams & Wilkins, 103 – 104.
Kranzhofer, R., Schmidt, J., Pfeiffer, C.A.H., Hagl, S., Libby, P. Kubler, W., 1999.
Angiotensin Induces Inflammatory Activation of Human Vascular Smooth
Muscle
Cells.
Available
From:
http://atvb.ahajournals.org/content/19/7/1623.long
[Accessed 22 Mei 2013].
Kurd, S.H., Troxel, A.B., Crits-Christoph, P., Gelfand, J.M., 2010. The Risk of
Depression, Anxiety, and Suicidality in Patients With Psoriasis. Arch
Dermatol, 146(8) : 891 – 895.
Universitas Sumatera Utara
37
Lee, C.T., Williams, G.H., Lilly, L.S., 2011. Hypertension. In : Lilly, L.S., ed.
Pathophysiology of Heart Disease a collaborative project of medical
students and faculty. 5th ed. Philadelphia : Lippincott Williams & Wilkins,
301 – 323.
Madanagobalane, S., Anandan, S., 2012. Prevalence of Metabolic Syndrome in
South Indian Patients with Psoriasis Vulgaris and the Relation Between
Disease Severity and Metabolic Syndrome : A Hospital-Based CaseControl Study. Indian J Dermatol, 57 : 353 – 357.
Mukhtar, Z., 2011. Desain Penelitian. Dalam : Mukhtar, Z., ed. Desain Penelitian
Klinis dan Statistika Kedokteran. 1st ed. Medan : USU press, 72 – 75.
Murad, A & Tobin, A.M., 2012. Cardiovascular Disease in Inflammatory
Disorders – Psoriasis and Psoriatic Arthritis. Available From :
www.intechopen.com/download/pdf/32661.
[Accessed 2 December 2013]
Naldi, L., Chatenoud, L., Belloni, A., Peserico, A., et al., 2005. Cigarette smoking,
body mass index, and stressful life events as risk factors for psoriasis :
results from an Italian case-control study. J Invest Dermatol, 125: 61-67.
National Heart, Lung, and Blood Institute, 2010. What is Hypotension?.
Available From : http://www.nhlbi.nih.gov/health/health-topics/topics/hyp/
[Accessed 2 December 2013]
Niehof, M. & Borlak, J., 2011. HNFalpha Dysfunction as a Molecular Rational
for Cyclosporine Induced Hypertension. PLoS ONE, 6(1) : e16319.
Nestle, F.O., Kaplan, D.H., Barker, J., 2009. Mechanisms of disease Psoriasis. N
Eng J Med, 361: 469 – 509.
Universitas Sumatera Utara
38
Rocha-Pereira, P., Santos-Silva, A., Rebelo, I., Figueiredo, A., Quintanilha, A.,
Teixeira, F., 2001. Dislipidemia and oxidative stress in mild and in severe
psoriasis as a risk for cardiovascular disease. Clinica Chimica Acta,
303:
33-29.
Schön, M.P., Boehncke, W.H., 2005. Medical Progress Psoriasis. N Eng J Med,
352: 1899 – 1912.
Sherwood, L. 2010. Human Physiology from cells to systems. 7th ed. USA :
Cengage Learning, 350 – 351.
Siregar, R.S., 2000. Psoriasis. Dalam : Harahap, W., ed. Ilmu Penyakit Kulit.
Jakarta : Hipokrates, 116 – 126.
Sowers, J.R., 2002. Hypertension, Angiotensin II, and Oxidative Stress. N Engl J
Med, 346: 1999–2001.
Strom, J.B., Libby, P., 2011. Atherosclerosis. In : Lilly, L.S., ed. Pathophysiology
of Heart Disease a collaborative project of medical students and faculty.
5th ed. Philadelphia : Lippincott Williams & Wilkins, 113-134.
Sugiharto, A. 2007. Faktor-Faktor risiko Hipertensi grade II pada masyarakat
(Studi Kasus di Kabupaten Karanganyar). Tesis. Semarang : Program
Studi Epidemiologi Program Pasca Sarjana Universitas Diponegoro.
Tortora, G.J., Derrickson, B., 2012. The Cardiovascular System: Blood Vessels
and Hemodynamics. In: Roesch, B., et al., eds. Principles of Anatomy and
Physiology. 13th ed. USA: John Wiley & Sons, 817.
Tozawa, M., Oshiro, S., Iseki, C., Sesoko, S., Higashiuesato, Y., Tana, T.,
Ikemiya,Y., Iseki, K., Fukiyama, K., 2001. Family History of
Hypertension
and
Blood
Pressure
in
Screened
Cohort.
Hypertens Res, 24 : 93 – 98.
Universitas Sumatera Utara
39
Wakkee, M., Thio, H.B., Prens, E.P., Sijbrands, E.J.G., Neumann, H.A.M., 2007.
Unfavorable cardiovascular risk profiles in untreated and treated psoriasis
patients. Atherosclerosis, 190: 1 - 9.
Wandeler, G., Paccaud, F., Vollenweider, P., Waeber, G., Mooser, V., Bochud,
M., 2010. Strength of Family History in Predicting Levels of Blood
Pressure, Plasma Glucose and Cholesterol. Public Health Genomics, 13 :
143 – 154.
Universitas Sumatera Utara